Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding

Ligands targeting tau for use with positron emission tomography have rapidly been developed during the past several years, enabling the in vivo study of tau pathology in patients with Alzheimer's disease and related non-Alzheimer's disease tauopathies. Several candidate compounds have been...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Alzheimers Dement (Amst)
Main Authors: Lemoine, Laetitia, Leuzy, Antoine, Chiotis, Konstantinos, Rodriguez-Vieitez, Elena, Nordberg, Agneta
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2018
נושאים:
Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956931/
https://ncbi.nlm.nih.gov/pubmed/29780868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.01.007
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים